Board of Directors
Research & Development
Apr 27, 2016
New LTX-315 article published in Cell Death and Differentiation
Title: The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade
Authors: T Yamazaki, JM Pitt, M Vétizou, A Marabelle, C Flores, Ø Rekdal, G Kroemer and L Zitvogel
This preclinical study further provides strong rationale for combining LTX-315 with checkpoint inhibitor anti CTLA4.
Read the article